Literature DB >> 16081642

Urocortin 2 suppresses host resistance to Listeria monocytogenes infection via up-regulation of interleukin-10.

Hiroshi Sashinami1, Kazunori Kageyama, Toshihiro Suda, Akio Nakane.   

Abstract

Previous studies have showed that corticotropin-releasing factor (CRF) modulates immune response during inflammation. We investigated the effect of CRF family peptides on host resistance to Listeria monocytogenes infection in mice. When mice were administered ip with CRF, urocortin (Ucn), or Ucn2 30 min prior a sublethal infection with L. monocytogenes, the numbers of bacteria in the organs of Ucn2-treated mice were dramatically increased, and most of these mice succumbed. However, host resistance to the infection was retained in CRF- or Ucn-treated mice. The suppressive effect of Ucn2 was dependent on CRF receptor type 2 because an antagonist to the receptor canceled the effect of Ucn2. IL-10 production was significantly increased, and interferon-gamma and TNFalpha production was decreased in the spleens of Ucn2-treated mice, compared with those in Ucn2-untreated control mice. The effect of Ucn2 was canceled by treatment with anti-IL-10 monoclonal antibody and in IL-10-deficient mice. The expression and activation of signal transducers and activators of transcription (STAT) 3 were up-regulated, and the expression and activation of STAT1 were down-regulated in the spleens from Ucn2-treated mice, compared with vehicle-treated mice. Moreover, suppression of TNFalpha production and augmentation of IL-10 production and expression and activation of STAT3 by Ucn2 treatment were observed in heat-killed L. monocytogenes-stimulated macrophages. These results suggested that Ucn2 suppresses host resistance to L. monocytogenes infection via up-regulation of IL-10 production.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081642     DOI: 10.1210/en.2005-0439

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Inflammation-induced functional connectivity of melanin-concentrating hormone and IL-10.

Authors:  Dimitrios C Ziogas; Apostolos K A Karagiannis; Brenda M Geiger; Beatriz Gras-Miralles; Robert Najarian; Ofer Reizes; Leo R Fitzpatrick; Efi Kokkotou
Journal:  Peptides       Date:  2014-02-18       Impact factor: 3.750

2.  Activation of phosphatidylinositol 3-kinase/protein kinase B by corticotropin-releasing factor in human monocytes.

Authors:  Christina Chandras; Yassemi Koutmani; Efi Kokkotou; Charalabos Pothoulakis; Katia P Karalis
Journal:  Endocrinology       Date:  2009-07-23       Impact factor: 4.736

3.  Corticotropin-Releasing Hormone Receptor 2 Signaling Promotes Mucosal Repair Responses after Colitis.

Authors:  Jill M Hoffman; Stavroula Baritaki; Jonathan J Ruiz; Aristea Sideri; Charalabos Pothoulakis
Journal:  Am J Pathol       Date:  2015-11-18       Impact factor: 4.307

4.  Urocortin prevents indomethacin-induced small intestinal lesions in rats through activation of CRF2 receptors.

Authors:  Yoshikazu Kubo; Aiko Kumano; Kohei Kamei; Kikuko Amagase; Naoko Abe; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2009-08-26       Impact factor: 3.199

5.  Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha.

Authors:  Alan C Moss; Pauline Anton; Tor Savidge; Paul Newman; Adam S Cheifetz; Jerome Gay; Sophia Paraschos; Michael Weinstein Winter; Mary P Moyer; Katia Karalis; Efi Kokkotou; Charalabos Pothoulakis
Journal:  Gut       Date:  2007-04-05       Impact factor: 23.059

6.  Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense.

Authors:  Ibtissam Echchgadda; Te-Hung Chang; Ahmed Sabbah; Imad Bakri; Yuji Ikeno; Gene B Hubbard; Bandana Chatterjee; Santanu Bose
Journal:  BMC Cancer       Date:  2011-01-28       Impact factor: 4.430

7.  Corticotropin Releasing Factor promotes breast cancer cell motility and invasiveness.

Authors:  Ariadne Androulidaki; Erini Dermitzaki; Maria Venihaki; Effie Karagianni; Olga Rassouli; Erini Andreakou; Christos Stournaras; Andrew N Margioris; Christos Tsatsanis
Journal:  Mol Cancer       Date:  2009-06-02       Impact factor: 27.401

8.  Passive immunization with anti-ActA and anti-listeriolysin O antibodies protects against Listeria monocytogenes infection in mice.

Authors:  Krisana Asano; Hiroshi Sashinami; Arihiro Osanai; Shouhei Hirose; Hisaya K Ono; Kouji Narita; Dong-Liang Hu; Akio Nakane
Journal:  Sci Rep       Date:  2016-12-22       Impact factor: 4.379

Review 9.  Hypothalamic Regulation of Corticotropin-Releasing Factor under Stress and Stress Resilience.

Authors:  Kazunori Kageyama; Yasumasa Iwasaki; Makoto Daimon
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.